`
Sunday, 25 June 2017

Drug Discovery News

  • Aussie firm likely to get orphan status for its new drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015

    Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee for Orphan Medicinal Products (COMP) for the designation of its drug ...Read more

  • Eisai, Nihon Medi-Physics to work on dementia intervention

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015

    Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement to contribute to the diagnosis and treatment of Dementia with Lewy b...Read more

  • French firm successfully completes Ph I trial of diabetes drug in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 28 May, 2015

    Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully conculded phase 1 clinical trial of its lead candidate, Imeglimin, in J...Read more

  • Eisai launches In-house anticancer agent in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 21 May, 2015

    Japan's leading pharmaceutical company Eisai Co. Ltd. has launched its in-house developed novel anticancer agent Lenvima Capsule 4 mg and 10 mg (lenvatinib mesylate, Lenvima) as a treatment...Read more

  • AstraZeneca invests in antisense therapies

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015

    Singapore: Isis Pharmaceuticals and AstraZeneca have made a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases based on nov...Read more

  • NIH launches clinical trial focused on HIV-related CV disease

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2015

    Singapore: Researchers have begun enrolling participants in to a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiov...Read more

  • Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015

    Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan's Mitsubishi Tanabe pharma. The deal, worth more than $500 millin, gi...Read more

  • Janssen seeks approval for drug resistant TB drug in EU

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012

    Singapore: Janssen-Cilag International NV (Janssen) submitted a marketing authorization application to the European Medicines Agency (EMA) seeking conditional approval for the use of the in...Read more

  • Thailand develops its first-ever indigenous drug

    Drug Discovery |  News | By Vipul Murarka | 0 Comment | 26 Dec, 2012

    Singapore: Thailand's former science and technology (S&T) minister, Professor Yongyuth Yuthavong, and his team have successfully developed Thailand's first indigenous drug for combating...Read more

  • J&J starts clinical trial of Ebola vaccine in Sierra Leone

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 12 Oct, 2015

    Johnson & Johnson (J&J) has announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pha...Read more

  • ASLAN's bile duct cancer drug receives orphan drug status

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015

    Singapore: Singapore's ASLAN pharmaceuticals recently announced that the Food and Drug Administration (FDA) has granted orphan drug designation to its pan-HER inhibitor ASLAN001 (varlitinib...Read more

  • TaiGen initiates clinical trial of leukemia drug in China

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 04 May, 2015

    Singapore: Taiwan's TaiGen Biotechnology has initiated first burixafor trial for relapsed or refractory acute myeloid leukemia in China. Burixafor is being studied in combination with two ...Read more

  • China approves Bayer's Xarelto

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 05 May, 2015

    Singapore: Bayer's anticoagulant drug, Xarelto (rivaroxaban), has been approved by the China Food and Drug Administration (CFDA) for the prevention of stroke and systemic embolism in adult ...Read more

  • ScinoPharm, Foresee form joint venture

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013

    Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form a joint venture. This venture will develop a series of peptide injec...Read more

  • Novogen's drug shows positive result for brain cancer

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2015

    Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in treating adult and pediatric brain cancer. The study looked at the a...Read more

  • Phosphagenics achieves biggest milestone yet

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013

    Singapore: Australian drug delivery technology company, Phosphagenics has achieved succes in its multi-dose oxymorphone patch phase I trial in 12 subjects. The phase I trial was conducted a...Read more

  • Aussie firm trials combination therapy for melanoma

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 29 Sep, 2015

    Singapore: Australia based Viralytics has initiated a clinical trial to assess its oncolytic virus, Cavatak, in combination with the checkpoint inhibitor Keytruda (pembrolizumab) in late-st...Read more

  • Aussie chemotherapy drug gets orphan designation

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2015

    Singappore: US Food and Drug Administration (FDA) has granted orphan drug designation to chemotherapy drug candidate Cantrixil for ovarian cancer developed by CanTx, a subsidiary joint vent...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls